ArticleDiabetes spectrum : a publication of the American Diabetes Association2019

Achievement of Target A1C <7.0% (<53 mmol/mol) by U.S. Type 2 Diabetes Patients Treated With Basal Insulin in Both Randomized Controlled Trials and Clinical Practice.

Lawrence Blonde et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.